Results 151 to 160 of about 13,200 (163)

Respiratory drugs and psychiatric adverse events in children and adolescents: a pharmacovigilance study based on the FAERS database. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Feng J, Zhao S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Risk of Psychiatric Adverse Events Among Montelukast Users

Journal of Allergy and Clinical Immunology: in Practice, 2021
Efe Eworuke, Sengwee Toh, Veronica Sansing‐Foster   +2 more
exaly  

Montelukast in hospitalized patients diagnosed with COVID-19

Journal of Asthma, 2022
Navaneeth Narayanan, Jared Radbel, Nikhil Yegya-Raman   +2 more
exaly  

The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies

Molecular Therapy, 2022
Yuksel Cetin, Yesim Yumak, Alisan Kayabolen   +2 more
exaly  

Pharmacokinetics, Bioavailability, and Safety of Montelukast Sodium (MK-0476) in Healthy Males and Females

Pharmaceutical Research, 1996
Jonathan A Leff, M de Smet, Haiyung Cheng   +2 more
exaly  

Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers

Biopharmaceutics and Drug Disposition, 1997
Haiyung Cheng, Jamie J Zhao, J D Rogers
exaly  

A review of montelukast in the treatment of asthma and allergic rhinitis

Expert Opinion on Pharmacotherapy, 2004
exaly